<DOC>
	<DOCNO>NCT02998099</DOCNO>
	<brief_summary>The purpose study evaluate effect age PK , safety tolerability IV rivipansel .</brief_summary>
	<brief_title>A Study Evaluate Effect Age Pharmacokinetics , Safety Tolerability IV Rivipansel .</brief_title>
	<detailed_description />
	<criteria>Healthy female subject nonchildbearing potential healthy male subject age 1845 year 65 year age old . Body mass index ( BMI ) 17.5 40 kg/m2 Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Pregnant female ; breastfeed female subject ; male subject partner currently pregnant Treatment another investigational drug within 30 day 5 halflives precede dose study medication Blood donation within 60 day prior dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Rivipansel</keyword>
</DOC>